How to win: Adrenaline Auto Injectors (AAIs) Partnerships

About this contract

Keeping children and young people with allergies safe while in school is a key priority for the Government. Section 34 of the Children’s Wellbeing and Schools Act 2026 (www.legislation.gov.uk/ukpga/2026/21/section/34/enacted) places new allergy safety duties on schools. We have published new statutory guidance on Allergy safety in schools (www.gov.uk/government/publications/allergy-safety-in-schools). Currently under the Human Medicines (Amendment) Regulations 2017, schools in England are permitted to purchase “spare” adrenaline auto-injectors (AAIs) without a prescription for emergency use in cases of anaphylaxis. The Government intends to require all schools to stock “spare” AAIs. Further education (FE) colleges and other post‑16 institutions are not included in this exemption. Any extension would require regulatory change, which has not yet been implemented. Suppliers should therefore continue to operate in line with the current legal framework. This early engagement supports the Department for Education’s (DfE) preparatory work ahead of new statutory guidance, with the aim of ensuring schools can access “spare” adrenaline auto-injectors (AAIs) quickly, reliably and affordably

How to win contracts like this

• ✓Answer against the marking scheme, not the question text — Department for Education scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for goods work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar goods contracts you've delivered for public bodies, with measurable outcomes.
• ✓Start early: it closes 31 July 2026 and a strong bid takes iteration.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts